A Study of TG103 Injection in Overweight or Obesity

Clinical trial NCT05299697 · UNKNOWN

Trial details

NCT number: NCT05299697
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2022-05-20
Primary completion: 2023-06-30
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.